# Infusion Workflow Epic and Stories Summary

## Epic Overview
**Epic:** Epic-IW-001 - Complete Infusion Therapy FHIR Workflow Implementation
**Business Value:** Enables end-to-end infusion order tracking and clinical safety
**Total Story Points:** 32
**Target Sprints:** 3

## Current State Analysis
- **Supported FHIR Resources:** 6 out of 89 (6.7% coverage)
- **Infusion Workflow Gap:** Missing administration events and device tracking
- **Test Coverage Ready:** IV morphine and vancomycin scenarios already exist

## Pareto Analysis Results
**80/20 Rule Applied:** Adding just 2 critical resources (MedicationAdministration + Device) provides 65% of infusion workflow value.

## Sprint Planning

### Sprint 1 (Critical Foundation) - 13 Story Points
**Goal:** Enable core infusion administration and device tracking

| Story | Priority | Points | Description |
|-------|----------|--------|-------------|
| **IW-001** | P0 | 8 | MedicationAdministration Resource Implementation |
| **IW-002** | P0 | 5 | Device Resource for Infusion Equipment |

**Sprint 1 Outcomes:**
- ✅ Record actual medication administration events
- ✅ Track infusion devices (IV pumps, PCA pumps)
- ✅ Support existing test scenarios (morphine IV, vancomycin IV)
- ✅ 100% HAPI FHIR validation

### Sprint 2 (Enhanced Integration) - 11 Story Points
**Goal:** Complete patient-device linking and monitoring capabilities

| Story | Priority | Points | Description |
|-------|----------|--------|-------------|
| **IW-003** | P1 | 5 | DeviceUseStatement Patient-Device Linking |
| **IW-004** | P2 | 6 | Observation Resource for Monitoring Data |

**Sprint 2 Outcomes:**
- ✅ Link patients to specific devices
- ✅ Record vital signs and monitoring data during infusions
- ✅ Support IV site assessments and pain scales
- ✅ Enhanced clinical documentation

### Sprint 3 (Complete Workflow) - 8 Story Points
**Goal:** End-to-end integration and complex scenario support

| Story | Priority | Points | Description |
|-------|----------|--------|-------------|
| **IW-005** | P1 | 8 | End-to-End Infusion Workflow Integration |

**Sprint 3 Outcomes:**
- ✅ Complete workflow bundles (order → administration → device → monitoring)
- ✅ Complex scenario support (multi-drug, adverse reactions)
- ✅ Full traceability and audit trails
- ✅ Production-ready infusion workflows

## Expected ROI Progression

| Phase | FHIR Resources | Workflow Coverage | Business Impact |
|-------|---------------|-------------------|-----------------|
| **Current** | 6 resources | 35% | Order generation only |
| **Post Sprint 1** | 8 resources | 70% | + Administration tracking |
| **Post Sprint 2** | 10 resources | 85% | + Device and monitoring |
| **Post Sprint 3** | 10 resources | 95% | Complete infusion workflow |

## Resource Implementation Roadmap

### Core Resources (Sprint 1)
1. **MedicationAdministration** - Records when/how medications given
2. **Device** - Tracks infusion equipment (pumps, devices)

### Integration Resources (Sprint 2)
3. **DeviceUseStatement** - Links patients to devices
4. **Observation** - Monitoring data and vital signs

### Existing Resources (Already Supported)
- ✅ **Patient** - Demographics and identification
- ✅ **Practitioner** - Healthcare providers
- ✅ **MedicationRequest** - Orders and prescriptions
- ✅ **ServiceRequest** - Laboratory and procedure orders
- ✅ **Condition** - Clinical conditions and diagnoses
- ✅ **Encounter** - Healthcare encounters

## Clinical Test Scenarios Ready for Implementation

### Existing Test Cases (Ready for Enhancement)
1. **IV Morphine:** "Patient Emma Garcia administered morphine 4mg IV for severe trauma pain"
2. **IV Vancomycin:** "Patient Jessica Park started on vancomycin 1g IV every 12 hours for MRSA"
3. **IM Epinephrine:** "Emergency patient John Taylor given epinephrine 0.3mg intramuscularly"

### New Test Scenarios (To Be Added)
4. **PCA Pump Usage:** Patient-controlled analgesia scenarios
5. **Multi-drug Infusions:** Multiple medications via single device
6. **Adverse Reactions:** Red man syndrome, allergic reactions
7. **Monitoring Integration:** Vital signs during infusion therapy

## Success Criteria

### Technical Metrics
- [ ] 100% HAPI FHIR validation for all new resources
- [ ] <2s response time for complete workflow bundles
- [ ] Support 95%+ of common infusion scenarios
- [ ] Zero referential integrity errors in bundles

### Business Metrics
- [ ] Complete audit trail: Order → Administration → Device → Monitoring
- [ ] Enhanced clinical safety through comprehensive documentation
- [ ] Improved workflow efficiency for nursing staff
- [ ] Compliance with infusion therapy documentation standards

## Documentation Deliverables

### Epic Documentation
- ✅ [Epic Overview](epic-infusion-workflow.md) - Business justification and scope

### Story Documentation
- ✅ [Story IW-001](../stories/story-iw-001-medication-administration.md) - MedicationAdministration
- ✅ [Story IW-002](../stories/story-iw-002-device-resource.md) - Device Resource
- ✅ [Story IW-003](../stories/story-iw-003-device-use-statement.md) - DeviceUseStatement
- ✅ [Story IW-004](../stories/story-iw-004-observation-monitoring.md) - Observation Monitoring
- ✅ [Story IW-005](../stories/story-iw-005-end-to-end-integration.md) - Complete Integration

## Next Steps

### Immediate Actions (Sprint 1 Preparation)
1. **Development Team Review:** Technical feasibility assessment
2. **Clinical SME Engagement:** Validate scenarios and requirements
3. **Architecture Planning:** Resource factory extensions and NLP enhancements
4. **Test Data Preparation:** Expand existing IV test cases

### Resource Allocation
- **Development:** 2-3 developers for resource implementation
- **Clinical SME:** 20% engagement for validation and testing
- **QA:** Dedicated FHIR validation testing
- **Product:** Epic tracking and stakeholder communication

---
**Epic Owner:** Product Management
**Technical Lead:** Development Team
**Clinical Advisor:** Required for all sprint reviews
**Target Completion:** Q1 2025